Suppressive effect of vitamin K2 (menatetrenone) against bone mineral density loss after radiotherapy in uterine cancer patients.
Kaneyasu Y, Fujiwara H, Akita T, Tanaka J, Shibata Y, Nakagawa T, Koh I, Hirata E, Hyodo M, Miyamoto T, Murakami Y, Nishibuchi I, Imano N, Nagata Y, Kudo Y.
Kaneyasu Y, et al. Among authors: miyamoto t.
Jpn J Radiol. 2025 Jan 24. doi: 10.1007/s11604-025-01733-5. Online ahead of print.
Jpn J Radiol. 2025.
PMID: 39849242